Search Results 281-290 of 17162 for egfr
Tumor harbors an EGFR-sensitizing (activating) mutation or an ALK translocation. Note: EGFR-sensitizing mutations are those mutations that are amenable to ...
Compromised renal function, defined as eGFR ≤30 (3,4). History of prior moderate or severe contrast reaction including: unresponsiveness, severe ...
When kidneys no longer function well enough to meet a body's needs, treatment involves kidney dialysis or kidney transplant.
Find out more about preemptive kidney transplant – an alternative to dialysis for treatment of end-stage kidney disease – and what to expect.
Some targeted therapies have been evaluated, including anti-angiogenic agents (e.g. bevacizumab, sunitinib, sorafenib) and. EGFR inhibitors (e.g. cetuximab), ...
... eGFR <15 ml/min/1.73 m). 327 patients were analyzed. Median follow-up was 88.1 months (interquartile range, 34.4-129.1). When race was removed from MDRD ...
* Has an estimated glomerular filtration rate eGFR of \<30 mL/min/1.73m\^2 at screening. * Has received prior or currently receiving TTR-lowering therapy.
Severely reduced kidney function (estimated glomerular filtration rate [eGFR] < 30 mL/min/1.73m^2 ), using the Chronic Kidney Disease Epidemiology ...
Severe kidney disease defined as estimated glomerular filtration rate (eGFR) <15 mL/minute/1.73m2, or kidney failure defined as receiving renal replacement ...
Known EGFR mutations which are sensitive to available targeted inhibitor ... All patients with non-squamous histology must have been tested for EGFR mutation ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.